Merge Healthcare (NASDAQ: MRGE) announced its earnings results on Wednesday. The company reported ($0.01) earnings per share for the quarter, missing the analysts’ consensus estimate of $0.04 by $0.05, AnalystRatingsNetwork.com reports. The company had revenue of $63.60 million for the quarter, compared to the consensus estimate of $63.69 million. During the same quarter last year, the company posted $0.03 earnings per share. Merge Healthcare’s revenue was up 4.3% compared to the same quarter last year.
Several analysts have also recently commented on the stock. Analysts at Craig Hallum upgraded shares of Merge Healthcare from a “hold” rating to a “buy” rating in a research note to investors on Wednesday, April 3rd. On the ratings front, analysts at Zacks reiterated a “neutral” rating on shares of Merge Healthcare in a research note to investors on Tuesday, April 2nd. They now have a $3.25 price target on the stock. Finally, analysts at B. Riley initiated coverage on shares of Merge Healthcare in a research note to investors on Thursday, March 28th. They set a “buy” rating on the stock.
One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Merge Healthcare currently has a consensus rating of “Buy” and a consensus price target of $4.44.
Shares of Merge Healthcare (NASDAQ: MRGE) opened at 3.12 on Wednesday. Merge Healthcare has a 52 week low of $2.20 and a 52 week high of $4.53. The stock’s 50-day moving average is currently $2.92. The company’s market cap is $291.6 million.
Merge Healthcare Incorporated (NASDAQ: MRGE) develops healthcare information software solutions and delivers related services.